FeesSafety
Pluang+
Home/Explore/US Market Price/Stocks/ASND
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Ascendis Pharma A/S (ASND) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Ascendis Pharma (ASND) trades at $258.45, down 0.54% on the day, with strong technical momentum indicated by bullish moving averages and ADX signals. The company shows impressive revenue growth from $720 million in 2025 to projected $1.0 billion in 2026, with net income turning positive to $742 million. Recent developments include regaining TransCon technology rights and a $400 million share repurchase program, while analyst consensus remains strongly bullish with a $306.33 price target.
The outlook remains positive with robust revenue growth and profitability improvements, though risks include high debt levels and pipeline execution challenges. The stock offers 18.5% upside to consensus target, supported by strong institutional sentiment and improving cash flow generation from commercial products.
Read full analysis

Key Stats

  • Market Cap
    $17.10B
  • Volume
    895,914
  • Sector
    Health
  • 52W High
    $277.18
  • 52W Low
    $196.63
  • Typical Hold Time
    58 Days
  • Enterprise Value
    $16.69B
  • Div Yield
    -
  • Trading Activity
    0% Sell | 100% Buy
$258.84
52W Low: $196.63
09 Dec 2025
52W High: $277.18
08 Jul 2026

Track Ascendis Pharma A/S (ASND) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Ascendis Pharma A/S has traded between a low of $196.63 and a high of $277.18, highlighting its annual price range. Buy and sell Ascendis Pharma A/S shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Ascendis Pharma A/S

Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.

Most Recent News

Content is generated by Aura AI

Dylanex offers key Q4 inventory tips for Amazon sellers to avoid stock-outs and manage holiday demand.

Dylanex has released practical guidance for Amazon sellers to prepare inventory for the busy Q4 holiday season. The advice focuses on managing inbound shipment timing, avoiding preparation errors, planning around restock limits, and using reserve sto...

Market News
49 minutes ago
Not Specified
Neutral
Dylanex offers key Q4 inventory tips for Amazon sellers to avoid stock-outs and manage holiday demand.

Australia project logistics market to grow to $10.27B by 2031, driven by mining and renewable energy projects

The Australia project logistics market is projected to grow from USD 7.88 billion in 2026 to USD 10.27 billion by 2031, at a CAGR of 5.52%. Growth is fueled by mining and energy projects requiring transport of oversized cargo, and expanding renewable...

Market News
49 minutes ago
Researchandmarkets.Com
Bullish
news icon
Australia project logistics market to grow to $10.27B by 2031, driven by mining and renewable energy projects

Investigation launched into Arbor Realty Trust for potential securities fraud after dividend suspension.

The Portnoy Law Firm is investigating Arbor Realty Trust, Inc. for possible securities fraud following the company's October 30, 2026 announcement to suspend its quarterly cash dividend due to financial challenges. This announcement caused Arbor's st...

Market News
1 hour ago
Portnoy Law Firm
Bearish
news icon
Investigation launched into Arbor Realty Trust for potential securities fraud after dividend suspension.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $17.10B
  • Volume
    895,914
  • Sector
    Health
  • 52W High
    $277.18
  • 52W Low
    $196.63
  • Typical Hold Time
    58 Days
  • Enterprise Value
    $16.69B
  • Div Yield
    -
  • Trading Activity
    0% Sell | 100% Buy
$258.84
52W Low: $196.63
09 Dec 2025
52W High: $277.18
08 Jul 2026

Track Ascendis Pharma A/S (ASND) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Ascendis Pharma A/S has traded between a low of $196.63 and a high of $277.18, highlighting its annual price range. Buy and sell Ascendis Pharma A/S shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!